David J. Foster
Keine laufenden Positionen mehr
Profil
Mr. David J.
Foster is on the Board of Directors at NovaRay Medical, Inc. and NovaRay, Inc.
Mr. Foster was previously employed as Chief Financial Officer, Secretary & Executive VP by Diadexus, Inc., Chief Financial Officer, Secretary & Executive VP by VaxGen, Inc., Secretary, Chief Financial Officer & Executive VP by diaDexus, Inc., Chief Financial Officer by Collagen Corp., Chief Executive Officer by Cohesion Technologies, Inc., and Chief Financial Officer by Argonaut Technologies, Inc.
He received his undergraduate degree from the University of California, Berkeley and an MBA from the University of California, Berkeley.
Ehemalige bekannte Positionen von David J. Foster
| Unternehmen | Position | Ende |
|---|---|---|
| DIADEXUS, INC. | Finanzdirektor/CFO | 07.07.2011 |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Finanzdirektor/CFO | 01.11.2010 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Finanzdirektor/CFO | 01.11.2010 |
Argonaut Technologies, Inc.
 Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | Finanzdirektor/CFO | 03.06.2005 |
| Collagen Corp. | Finanzdirektor/CFO | 01.01.1997 |
Ausbildung von David J. Foster
| University of California, Berkeley | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Argonaut Technologies, Inc.
Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | Commercial Services |
| Collagen Corp. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
NovaRay Medical, Inc.
 NovaRay Medical, Inc. Medical SpecialtiesHealth Technology NovaRay Medical, Inc. operates as a medical imaging company that focuses on developing innovations in proprietary digital cardiac x-ray technology. The company was founded by Marc Chester Whyte in June 2005 and is headquartered in Newark, CA. | Health Technology |
NovaRay, Inc.
 NovaRay, Inc. Medical SpecialtiesHealth Technology NovaRay, Inc. operates as a medical imaging firm. It develops digital cardiac x-ray technology. The company was founded in 2005 and is headquartered in Newark, CA. | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Angiotech BioMaterials Corp.
 Angiotech BioMaterials Corp. BiotechnologyHealth Technology Angiotech BioMaterials Corp. develops tissue repair and regeneration technology. The company was founded by David J. Foster in June 1997 and is headquartered in Palo Alto, CA. | Health Technology |
